News

Filter

Current filters:

Taxotere

1 to 9 of 361 results

Brazil Court annuls marketing approval for sub-standard Taxotere biosimilar

Brazil Court annuls marketing approval for sub-standard Taxotere biosimilar

28-11-2013

The Superior Court of Justice in Brazil recently annulled marketing approval for a sub-standard biosimilar…

BiosimilarsDoxelibGenericsLegalLibra LaboratoryOncologyRegulationSanofiSouth AmericaTaxotere

Oncologists backing of combo products supporting cytotoxic market

13-05-2012

The popularity of combination therapies in the treatment of cancer is set to increase, which will help…

BiotechnologyGemzarMarkets & MarketingOncologyPharmaceuticalTaxotere

Clinical gold-standard treatment for metastatic first-line HER2-positive breast cancer in 2015

05-02-2012

Based on clinical data and the opinions of interviewed thought leaders, Roche/Genentech/Chugai’s…

Asia-PacificEuropeHerceptinMarkets & MarketingNorth AmericaOncologyPharmaceuticalRocheTaxotere

Hospira’s first-quarter 2011 results beat forecasts, helped by generic Taxotere

27-04-2011

Specialty drugmaker Hospira (NYSE: HSP) yesterday reported results for the first quarter ended March…

FinancialGenericsHospiraTaxotere

Hospira gains US clearance for first generic of Sanofi-Aventis’ Taxotere

10-03-2011

USA-based Hospira (NYSE: HSP), a specialist in generic injectable pharmaceuticals, yesterday revealed…

docetaxelGenericsHospiraMarkets & MarketingNorth AmericaOncologyPatentsPharmaceuticalSanofi-AventisTaxotere

1 to 9 of 361 results

Back to top